Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Laufer

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Journal of Nurse-Midwifery|January 1, 1987
Vaginal birth after cesarean section. Nurse-midwifery managementA Laufer, V Hodenius, L Friedman, et al.
Journal of Medicinal Chemistry|September 3, 2021
Chemical Probes for Understudied Kinases: Challenges and OpportunitiesRicardo A M Serafim, Jonathan M Elkins, William J Zuercher, et al.
Computational and Structural Biotechnology Journal|July 5, 2022
Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonistAzam Rashidian, Enni-Kaisa Mustonen, Thales Kronenberger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2015
Role of p38 mitogen-activated protein kinase in linking stearoyl-CoA desaturase-1 activity with endoplasmic reticulum homeostasisAndreas Koeberle, Carlo Pergola, Hideo Shindou, et al.
Journal of Medicinal Chemistry|February 4, 2005
Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitorsStefan A Laufer, David M Domeyer, Thomas R F Scior, et al.
Journal of Medicinal Chemistry|June 9, 2012
Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinaseSolveigh C Koeberle, Stefan Fischer, Dieter Schollmeyer, et al.
Methods in Enzymology|May 28, 2023
Structural elements that enable specificity for mutant EGFR kinase domains with next-generation small-molecule inhibitorsTahereh Damghani, Florian Wittlinger, Tyler S Beyett, et al.
Infection and Immunity|July 1, 1995
Alternate routes of invasion may affect pathogenesis of Salmonella typhimurium in swineP J Fedorka-Cray, L C Kelley, T J Stabel, et al.
Human Mutation|November 26, 1999
Cystic fibrosis mutations in Israeli Arab patientsA Laufer-Cahana, I Lerer, M Sagi, et al.
Journal of Medicinal Chemistry|October 18, 2013
Metabolically stable dibenzo[b,e]oxepin-11(6H)-ones as highly selective p38 MAP kinase inhibitors: optimizing anti-cytokine activity in human whole bloodBenjamin Baur, Kirsten Storch, Kathrin E Martz, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Journal of Nurse-Midwifery|January 1, 1987
Vaginal birth after cesarean section. Nurse-midwifery managementA Laufer, V Hodenius, L Friedman, et al.
Journal of Medicinal Chemistry|September 3, 2021
Chemical Probes for Understudied Kinases: Challenges and OpportunitiesRicardo A M Serafim, Jonathan M Elkins, William J Zuercher, et al.
Computational and Structural Biotechnology Journal|July 5, 2022
Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonistAzam Rashidian, Enni-Kaisa Mustonen, Thales Kronenberger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2015
Role of p38 mitogen-activated protein kinase in linking stearoyl-CoA desaturase-1 activity with endoplasmic reticulum homeostasisAndreas Koeberle, Carlo Pergola, Hideo Shindou, et al.
Journal of Medicinal Chemistry|February 4, 2005
Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitorsStefan A Laufer, David M Domeyer, Thomas R F Scior, et al.
Journal of Medicinal Chemistry|June 9, 2012
Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinaseSolveigh C Koeberle, Stefan Fischer, Dieter Schollmeyer, et al.
Methods in Enzymology|May 28, 2023
Structural elements that enable specificity for mutant EGFR kinase domains with next-generation small-molecule inhibitorsTahereh Damghani, Florian Wittlinger, Tyler S Beyett, et al.
Infection and Immunity|July 1, 1995
Alternate routes of invasion may affect pathogenesis of Salmonella typhimurium in swineP J Fedorka-Cray, L C Kelley, T J Stabel, et al.
Human Mutation|November 26, 1999
Cystic fibrosis mutations in Israeli Arab patientsA Laufer-Cahana, I Lerer, M Sagi, et al.
Journal of Medicinal Chemistry|October 18, 2013
Metabolically stable dibenzo[b,e]oxepin-11(6H)-ones as highly selective p38 MAP kinase inhibitors: optimizing anti-cytokine activity in human whole bloodBenjamin Baur, Kirsten Storch, Kathrin E Martz, et al.
Pageof 19